Lipocine says Bloom study topline results expected in second half of 2027
LPCN•Lipocine said topline results from its Bloom study are expected in the second half of 2027, according to an SEC filing.
1. Results timing
Lipocine said topline results from its Bloom study are expected in the second half of 2027, according to an SEC filing.
